When discussing high cost drugs proven to cure a specific illness, such as hepatitis C treatment, it’s important to keep the following in mind:
All stakeholders - manufacturers, pharmacy benefit managers, pharmacies, payers and business owners - want a say in determining the cost of certain drugs because they all assume a certain level of risk. Healthcare stakeholders want to be sure that their risks are factored into the final price, and moving forward there will be much more coordination and collaboration between stakeholders to determine that price.
To learn more about Curant Health, contact Kristin Lindsey, Marketing Director, at klindsey@curanthealth.com.